Your browser doesn't support javascript.
Transmission of SARS-CoV-2 in the household setting: A prospective cohort study in children and adults in England.
Miller, Elizabeth; Waight, Pauline A; Andrews, Nick J; McOwat, Kelsey; Brown, Kevin E; Höschler, Katja; Ijaz, Samreen; Letley, Louise; Haskins, Donna; Sinnathamby, Mary; Cuthbertson, Hannah; Hallis, Bassam; Parimalanathan, Vaishnavi; de Lusignan, Simon; Lopez-Bernal, Jamie.
  • Miller E; PHE Immunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, NW9 5EQ London, United Kingdom. Electronic address: liz.miller@phe.gov.uk.
  • Waight PA; PHE Immunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, NW9 5EQ London, United Kingdom. Electronic address: pauline.kaye@phe.gov.uk.
  • Andrews NJ; Data and Analytical Sciences, Public Health England, 61 Colindale Avenue, NW9 5EQ London, United Kingdom. Electronic address: nick.andrews@phe.gov.uk.
  • McOwat K; PHE Immunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, NW9 5EQ London, United Kingdom. Electronic address: kelsey.mcowat@phe.gov.uk.
  • Brown KE; PHE Immunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, NW9 5EQ London, United Kingdom. Electronic address: kevin.brown@phe.gov.uk.
  • Höschler K; National Infection Services Laboratories, Public Health England, 61 Colindale Avenue, NW9 5EQ London, United Kingdom. Electronic address: Katja.hoschler@phe.gov.uk.
  • Ijaz S; National Infection Services Laboratories, Public Health England, 61 Colindale Avenue, NW9 5EQ London, United Kingdom. Electronic address: samreen.ijaz@phe.gov.uk.
  • Letley L; PHE Immunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, NW9 5EQ London, United Kingdom. Electronic address: louise.letley@phe.gov.uk.
  • Haskins D; PHE Immunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, NW9 5EQ London, United Kingdom. Electronic address: donna.haskins@phe.gov.uk.
  • Sinnathamby M; PHE Immunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, NW9 5EQ London, United Kingdom. Electronic address: mary.sinnathamby@phe.gov.uk.
  • Cuthbertson H; Immunoassay Laboratory,  National Infection Service, Public Health England, Porton Down SP4 0JG, United Kingdom. Electronic address: hannah.cutherbertson@phe.gov.uk.
  • Hallis B; Immunoassay Laboratory,  National Infection Service, Public Health England, Porton Down SP4 0JG, United Kingdom. Electronic address: bassan.hallis@phe.gov.uk.
  • Parimalanathan V; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG United Kingdom  and  Royal College of General Practitioners Research and Surveillance Centre, Euston Square, London NW1 2FB, United Kingdom. Electronic address: vp16@utas.edu.au.
  • de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG United Kingdom  and  Royal College of General Practitioners Research and Surveillance Centre, Euston Square, London NW1 2FB, United Kingdom. Electronic address: simon.delusignan@phc.ox.ac.uk.
  • Lopez-Bernal J; PHE Immunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, NW9 5EQ London, United Kingdom. Electronic address: Jamie.LopezBernal2@phe.gov.uk.
J Infect ; 83(4): 483-489, 2021 10.
Article in English | MEDLINE | ID: covidwho-1330976
ABSTRACT

OBJECTIVES:

To measure secondary attack rates (SARs) in prospectively followed household contacts of paediatric and adult cases of SARS-CoV-2 infection in England.

METHODS:

Self-taken nasal swabs from household contacts of PCR confirmed cases of COVID-19  and blood samples  on day 35 were tested for evidence of infection with SARS-CoV-2 virus.

RESULTS:

The secondary attack rate (SAR) among 431 contacts of 172 symptomatic index cases  was 33% (95% confidence intervals [CI] 25-40) and was lower from primary cases without respiratory symptoms, 6% (CI 0-14) vs 37% (CI 29-45), p = 0.030. The SAR from index cases <11 years  was  25% (CI 12-38). SARs ranged from 16% (4-28) in contacts <11 years old to 36% (CI 28-45) in contacts aged 19-54 years (p = 0.119). The proportion infected who developed symptoms (78%) was similar by age (p = 0.44) though <19 year olds had fewer mean number of symptoms than adults (p = 0.001) and fewer reported loss of sense of taste or smell (p = 0.0001).

CONCLUSIONS:

There are high risks of  transmission of SARS-CoV-2 virus in the home, including those where infection is introduced by a child. The risk of children acquiring infection was lower than that in adults and fewer developed typical symptoms of Covid-19 infection.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Child / Humans Language: English Journal: J Infect Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Child / Humans Language: English Journal: J Infect Year: 2021 Document Type: Article